During the past decade, Synexus Midlands Clinical Research Centre conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Midlands Clinical Research Centre" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Coloplast A/S" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Bellus Health Inc" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Midlands Clinical Research Centre" #1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Midlands Clinical Research Centre" are "Cardiovascular Disease" (2 trials), "Colostomy" (2 trials), "Crohn's Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials) and "Hyperlipidemia" (2 trials). Many other conditions were trialed in "Synexus Midlands Clinical Research Centre" in a lesser frequency.

Most popular intervention types in "Synexus Midlands Clinical Research Centre" are "Drug" (18 trials), "Biological" (3 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Bococizumab (PF-04950615; RN316)" (2 trials), "CC-93538" (2 trials), "Lasmiditan" (2 trials) and "Ustekinumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Midlands Clinical Research Centre" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Synexus Midlands Clinical Research Centre". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Synexus Midlands Clinical Research Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Midlands Clinical Research Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".